Literature DB >> 32606111

Bilateral acute anterior uveitis and iris atrophy caused by moxifloxacin.

Benjamin Tsun Kiu Hui1, Nicholas Capewell1, Yousuf Ansari1, Xiaoxuan Liu2,3,4.   

Abstract

A 56-year-old paramedic was admitted to hospital and treated for severe pneumonia. Shortly after initiating antibiotic treatment (including moxifloxacin), he developed bilaterally painful eyes and was diagnosed with bilateral acute anterior uveitis (AAU). Three years later, he was referred to the ophthalmology clinic with bilateral iris transillumination suggesting iris atrophy and limited pupillary dilation, indicating iris sphincter muscle paralysis. AAU typically presents unilaterally. An onset of bilateral AAU is unusual and warrants investigation for underlying systemic cause. The fluoroquinolone moxifloxacin has been reported in a limited number of cases as a causative agent of bilateral AAU and iris atrophy. This case provides additional supporting evidence that moxifloxacin may cause degradation of collagen and iris muscle in the eye, as well as elsewhere in the body, such as in blood vessels. Additionally, we present novel anterior segment ocular imaging (using optical coherence tomography) demonstrating the ability to detect iris atrophy using non-invasive imaging. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anterior chamber; iris

Mesh:

Substances:

Year:  2020        PMID: 32606111      PMCID: PMC7328819          DOI: 10.1136/bcr-2019-233528

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Investigation and management of uveitis.

Authors:  Catherine M Guly; John V Forrester
Journal:  BMJ       Date:  2010-10-13

2.  [Moxifloxacin and iris transillumination].

Authors:  A Broens; N Collignon
Journal:  Rev Med Liege       Date:  2015-12

3.  Anterior uveitis with sectoral iris atrophy in the absence of keratitis: a distinct clinical entity among herpetic eye diseases.

Authors:  A Van der Lelij; F M Ooijman; A Kijlstra; A Rothova
Journal:  Ophthalmology       Date:  2000-06       Impact factor: 12.079

Review 4.  [Drug induced uveitis].

Authors:  J Cano Parra; M Díaz-Llopis
Journal:  Arch Soc Esp Oftalmol       Date:  2005-03

5.  Degree, duration, and causes of visual loss in uveitis.

Authors:  O M Durrani; N N Tehrani; J E Marr; P Moradi; P Stavrou; P I Murray
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

6.  [Acute and bilateral uveitis secondary to moxifloxacin].

Authors:  R Bringas Calvo; D Iglesias Cortiñas
Journal:  Arch Soc Esp Oftalmol       Date:  2004-07

7.  Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

Authors:  M Wefers Bettink-Remeijer; K Brouwers; L van Langenhove; P W T De Waard; T O Missotten; J P Martinez Ciriano; E Van Aken
Journal:  Eye (Lond)       Date:  2009-12       Impact factor: 3.775

8.  An unusual case of bilateral anterior uveitis related to moxifloxacin: the first report in Latin America.

Authors:  Carlos M Rangel; M Margarita Parra; Gabriel Frederick; Alejandro Tello; Clara L Varón
Journal:  GMS Ophthalmol Cases       Date:  2017-07-07

9.  Moxifloxacin Concentration and Proteomic Analysis of Aqueous Humor in Human Uveitis Associated with Oral Moxifloxacin Therapy.

Authors:  David M Hinkle; Nicole A Kruh-Garcia; Jonathan N Kruh; Carolyn Broccardo; Priyanka Doctor; C Stephen Foster
Journal:  Open Ophthalmol J       Date:  2017-06-12

Review 10.  Ocular ischemic syndrome - a systematic review.

Authors:  Barbara Terelak-Borys; Katarzyna Skonieczna; Iwona Grabska-Liberek
Journal:  Med Sci Monit       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.